Attention deficit hyperactivity disorder (adhd) Trials in Memphis, United States
Conditions / Attention deficit hyperactivity disorder (adhd) / Memphis, United States
Research into Attention deficit hyperactivity disorder (adhd) spans multiple therapeutic approaches and trial phases.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02618408 | Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 1) | COMPLETED | PHASE3 |
| NCT04016779 | Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD | COMPLETED | PHASE3 |
| NCT03260205 | Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD) | COMPLETED | PHASE3 |
| NCT02466386 | Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder | COMPLETED | PHASE3 |
| NCT07226219 | Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease | RECRUITING | — |
| NCT02604407 | Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD) | COMPLETED | PHASE3 |
| NCT00500071 | Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD | COMPLETED | PHASE4 |
| NCT03325894 | Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) | TERMINATED | PHASE3 |
| NCT00735371 | Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) | COMPLETED | PHASE3 |
| NCT02477748 | The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD | TERMINATED | PHASE3 |